The Role of Renal Sympathetic Nerves in Hypertension: Has Percutaneous Renal Denervation Refocused Attention on Their Clinical Significance?

Progress in Cardiovascular Diseases

Volumn 52, Issue 3, 2009, Pages 243-248

  Katholi, Richard E ^a   Rocha Singh, Krishna J ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Prairie Education and Research Cooperative   (United States)

Author keywords

Denervation; Hypertension; Radioablation; Renal nerves

Indexed keywords

ARTERY CATHETERIZATION; ARTICLE; CHEMORECEPTOR; EFFERENT NERVE; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; KIDNEY DENERVATION; KIDNEY NERVE; MECHANORECEPTOR; NONHUMAN; RADIOFREQUENCY ABLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; RISK FACTOR; SYMPATHETIC NERVE; VASOCONSTRICTION;

AFFERENT PATHWAYS; CATHETER ABLATION; EFFERENT PATHWAYS; HUMANS; HYPERTENSION; KIDNEY; SYMPATHECTOMY;

EID: 71549129594     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2009.09.003     Document Type: Article

References (34)

1. Kearney P.M., Whelton M., Reynolds K., et al. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
2. Katholi R.E. Renal nerves in the pathogenesis of hypertension in experimental animals and humans. Am J Physiol 245 (1983) F1-F14
3. Katholi R.E. Renal nerves and hypertension: an update. Fed Proc 44 (1985) 2846-2850
4. DiBona G.F. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertension 11 (2002) 197-200
5. Krum H., Schlaish M., Whitbourn R., et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 60566-60573 10.1016/S0140-6736 [published online March 30]
6. Bell-Reuss E., Trevino D.L., and Gottschalk C.W. Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption. J Clin Invest 57 (1976) 1104-1107
7. DiBona G.F., and Kopp U.C. Neural control of renal function. Physiol Rev 77 (1997) 75-197
8. DiBona G.F. Neural control of the kidney: past, present and future. Hypertension 41 (2003) 621-624
9. Kon V. Neural control of renal circulation. Miner Electrolyte Metab 15 (1989) 33-43
10. Kirchheim H., Ehmke H., and Persson P. Sympathetic modulation of renal hemodynamics, renin release and sodium excretion. Klin Wochenschr 67 (1989) 858-864
11. Zanchetti A.S. Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension. Circulation 56 (1977) 691-698
12. Holmer S., Rinne B., Eckardt K.U., et al. Role of renal nerves for the expression of renin in adult rat kidney. Am J Physiol 266 (1994) F 738-F 745
13. Schultz H.D., Li Y.L., and Ding Y. Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension 50 (2007) 6-13
14. Zucker I.H. Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48 (2007) 1005-1011
15. Kopp U.C., Cicha M.Z., Smith L.A., et al. Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of alpha1- and alpha2-adrenoceptors on renal sensory nerve fibers. Am J Physiol Regul Integr Comp Physiol 293 (2007) R1561-R1572
16. Katholi R.E., Carey R.M., Ayers C.R., et al. Production of sustained hypertension by chronic intrarenal norepinephrine infusion in conscious dogs. Circ Res 40 Suppl. I (1977) 118-126
17. Doumas M., and Douma S. Interventional management of resistant hypertension. Lancet (2009) 60624-60633 10.1016/50l40-6736 [published online March 30]
18. Campese V.M., Kogosov E., and Koss M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 26 (1995) 861-865
19. Ye S., Zhong H., Yanamadala V., et al. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertension 15 (2002) 717-724
20. Katholi R.E., Hageman G.R., Whitlow P.L., et al. Hemodynamic and afferent renal nerve responses to intrarenal adenosine in the dog. Hypertension 5 Supp I (1983) I-149-I-154
21. Katholi R.E., Whitlow P.L., Hageman G.R., et al. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertension 2 (1984) 349-359
22. Katholi R.E., Taylor G.J., McCann W.P., et al. Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 195 (1995) 17-22
23. McQueen D.S., and Ribeiro J.A. Effect of adenosine on carotid chemoreceptor activity in the cat. Br J Pharmacol 74 (1981) 129-136
24. Gordon R.D., Bachman A.W., Jackson R.V., et al. Increased sympathetic activity in renovascular hypertension in man. Clin Exp Pharmacol Physiol 9 (1982) 277-281
25. Hausberg M., Kosch M., Harmelinck P., et al. Sympathetic nerve activity in end-stage renal disease. Circulation 106 (2002) 1974-1979
26. Schlaich M.P., Socratous F., Hennebry S., et al. Sympathetic activation in chronic renal failure. J Am Soc Nephrol (2009) [in press]
27. Peet M.M. Results of subdiaphragmatic splanchnicectomy for arterial hypertension. N Eng J Med 236 (1947) 270-276
28. Morrissey D.M., Brooks V.S., and Cooke W.T. Sympathectomy in the treatment of hypertension: review of 122 cases. Lancet 1 (1953) 403-408
29. Smithwick R.H., and Thompson J.E. Splanchnicectomy for essential hypertension: results in 1,266 cases. J Am Med Assoc 152 (1953) 1501-1504
30. Evelyn K.A., Singh M.M., Chapman W.P., et al. Effect of thoracolumbar sympathectomy on the clinical course of primary (essential) hypertension. A ten-year study of 100 sympathectomized patients compared with individually matched, symptomatically treated control subjects. Am J Med 28 (1960) 188-221
31. DiBona G.F. Renal innervation and denervation: lessons from renal transplantation reconsidered. Artif Organs 11 (1987) 457-462
32. Baumbach G. Mechanisms of vascular remodeling. In: Isso J.L., and Black H.R. (Eds). Hypertension primer. 3rd ed (2003), Lippincott Williams and Wilkins, Philadelphia (Pa) 180-183
33. Joles J.A., and Koomans H.A. Causes and consequences of increased sympathetic activity in renal disease. Hypertension 43 (2004) 699-706
34. Grassi G., Seravalle G., Quarti-Trevano F., et al. Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives. Hypertension 52 (2008) 925-931